111 related articles for article (PubMed ID: 16418208)
1. Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer.
Sáez C; Martínez-Brocca MA; Castilla C; Soto A; Navarro E; Tortolero M; Pintor-Toro JA; Japón MA
J Clin Endocrinol Metab; 2006 Apr; 91(4):1404-9. PubMed ID: 16418208
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlations of Bcl-xL and Bax expression in differentiated thyroid carcinoma.
Martínez-Brocca MA; Castilla C; Navarro E; Amaya MJ; Travado P; Japón MA; Sáez C
Clin Endocrinol (Oxf); 2008 Feb; 68(2):190-7. PubMed ID: 17803695
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
4. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
[TBL] [Abstract][Full Text] [Related]
5. Risk and prognostic factors for differentiated thyroid cancer.
Duntas L; Grab-Duntas BM
Hell J Nucl Med; 2006; 9(3):156-62. PubMed ID: 17160155
[TBL] [Abstract][Full Text] [Related]
6. Transforming events in thyroid tumorigenesis and their association with follicular lesions.
Heaney AP; Nelson V; Fernando M; Horwitz G
J Clin Endocrinol Metab; 2001 Oct; 86(10):5025-32. PubMed ID: 11600580
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
[TBL] [Abstract][Full Text] [Related]
8. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias.
Sáez C; Japón MA; Ramos-Morales F; Romero F; Segura DI; Tortolero M; Pintor-Toro JA
Oncogene; 1999 Sep; 18(39):5473-6. PubMed ID: 10498901
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of calcifications in thyroid carcinoma and multinodular goiter.
Consorti F; Anello A; Benvenuti C; Boncompagni A; Giovannone G; Moles N; Scardella L; Antonaci A
Anticancer Res; 2003; 23(3C):3089-92. PubMed ID: 12926167
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
12. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
Omar E; Madhavan M; Othman NH
Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma.
Hsueh C; Lin JD; Chang YS; Hsueh S; Chao TC; Yu JS; Jung SM; Tseng NM; Sun JH; Kuo SY; Ueng SH
Clin Endocrinol (Oxf); 2013 Feb; 78(2):303-9. PubMed ID: 22888961
[TBL] [Abstract][Full Text] [Related]
16. An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family.
Prezant TR; Kadioglu P; Melmed S
J Clin Endocrinol Metab; 1999 Mar; 84(3):1149-52. PubMed ID: 10084610
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.
Pei L; Xie P; Zhou E; Yang Q; Luo Y; Tang Z
Mol Med Rep; 2011; 4(5):817-23. PubMed ID: 21643629
[TBL] [Abstract][Full Text] [Related]
19. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
